Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia

NCT07714070 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Neoplasms
Endometrial Cancer
Atypical Endometrial Hyperplasia
Progestin Resistance

Interventions

DRUG: Orlistat
DRUG: Progestin

Sponsor

Peking University People's Hospital